HAO · Haoxi Health Technology Limited

This Form 6-K reports the dismissal of Wei, Wei & Co., LLP as Haoxi Health Technology Limited’s independent registered public accounting firm, effective April 6, 2026. The firm had audited the Company’s consolidated financial statements for the two most recent fiscal years ended June 30, 2025 and 2024. The filing includes Exhibit 16.1 — a letter from the former auditor addressed to the SEC — confirming that no disagreements occurred on accounting principles or financial reporting matters during the engagement period, which spanned from August 3, 2022 through April 6, 2026. While the filing does not name the successor auditor or disclose reasons for the change, the absence of disclosed disagreements is a positive signal regarding financial statement integrity. Auditor changes are material to investors because they may reflect governance shifts, regulatory scrutiny, or operational transitions; however, without further detail on rationale or successor appointment, the event carries medium materiality. Investors should monitor subsequent filings for disclosure of the new auditor and any related disclosures under Item 4.01 of Regulation S-K.